.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Army
QuintilesIMS
Dow
Accenture
Healthtrust
Colorcon
Harvard Business School
Deloitte
Daiichi Sankyo

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,508,269

« Back to Dashboard

Summary for Patent: 5,508,269

Title: Aminoglycoside formulation for aerosolization
Abstract:An aminoglycoside formulation for delivery by aerosolization. The concentrated aminoglycoside formulation containing an efficacious amount of aminoglycoside able to inhibit 95-100% of susceptible bacteria. Aminoglycoside formulated in 5 ml solution of a quarter normal saline having pH between 5.5 and 6.5. The method for treatment of endobronchial infections by a produced by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 .mu., produced by a jet or ultrasonic nebulizer.
Inventor(s): Smith; Arnold L. (Columbia, MO), Ramsey; Bonnie W. (Seattle, WA), Montgomery; Alan B. (Bellevue, WA)
Assignee: Pathogenesis Corporation (Seattle, WA)
Application Number:08/325,705
Patent Claim Types:
see list of patent claims
Formulation; Use;

No matches for this query

International Patent Family for Patent: 5,508,269

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2179305► Subscribe
Germany69511374► Subscribe
Denmark0734249► Subscribe
Australia3952295► Subscribe
Australia688166► Subscribe
European Patent Office0734249► Subscribe
Austria183080► Subscribe
Spain2136883► Subscribe
Greece3031770► Subscribe
JapanH09511254► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Johnson and Johnson
QuintilesIMS
Chubb
Accenture
McKesson
Harvard Business School
Fish and Richardson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot